HCATNasdaqServices-Computer Programming, Data Processing, Etc.Fiscal year ends December 31
Health Catalyst, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$1.71−0.02 (-0.87%)
Close on Oct 19, 2026
- Market cap
- $126.47M
- P/E (TTM)
- –
- Dividend yield
- –
Health Catalyst, Inc. revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Technology | $208.28M | $194.85M | $187.58M | $176.29M | $147.72M | $110.47M | $83.98M | $57.22M | $31.69M | 66.9% | +6.9% |
| Accumulated Impairment Losses | $102.86M | $111.73M | $108.36M | $99.95M | $94.21M | $78.38M | $70.97M | $55.35M | $41.39M | 33.1% | -7.9% |
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Technology | $208.28M | $194.85M | $187.58M | $176.29M | $147.72M | $110.47M | $83.98M | $57.22M | $31.69M | 66.9% | +6.9% |
| Recurring technology | $208.28M | $194.85M | $187.23M | $175.81M | $147.45M | $110.47M | $83.79M | $55.27M | $28.00M | 66.9% | +6.9% |
| Accumulated Impairment Losses | $102.86M | $111.73M | $108.36M | $99.95M | $94.21M | $78.38M | $70.97M | $55.35M | $41.39M | 33.1% | -7.9% |
| One-time technology (i.e., perpetual license) | $0 | $0 | $357.00K | $480.00K | $272.00K | $0 | $184.00K | $1.96M | $3.69M | 0.0% | – |
By region
From the segment and revenue-disaggregation notes of Health Catalyst's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.